成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook--->CAS DataBase List--->17743-04-3

17743-04-3

17743-04-3 Structure

17743-04-3 Structure
IdentificationBack Directory
[Name]

dihydro-6-imino-1,3-dimethyluracil
[CAS]

17743-04-3
[Synonyms]

Einecs 241-736-4
Doxofylline Impurity 27
1,3-dimethyl-6-iminouracil
dihydro-6-imino-1,3-dimethyluracil
2,4(1H,3H)-Pyrimidinedione, dihydro-6-imino-1,3-dimethyl-
5,6-Dihydro-6-imino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
[EINECS(EC#)]

241-736-4
[Molecular Formula]

C6H9N3O2
[MOL File]

17743-04-3.mol
[Molecular Weight]

155.15
Chemical PropertiesBack Directory
[Boiling point ]

204.7±23.0 °C(Predicted)
[density ]

1.38±0.1 g/cm3(Predicted)
[pka]

1.96±0.20(Predicted)
17743-04-3 suppliers list
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522 , +8615391658522
Website: https://www.standardpharm.org.cn/
Company Name: Guangzhou CATO Research Chemicals Inc.
Tel: +86-020-81960175-617 +8615602392859 , +8615602392859
Website: www.cato-chem.com/
Company Name: ChengDu SinoStandards Bio-Tech Co.,Ltd. ,  
Tel: 028-83243028 19136088901
Website: www.ebuylabs.com/
Company Name: Changzhou Xianglong Pharmaceutical Technology Co., LTD  
Tel: 0519-88910898 18661161657
Website: www.xianglongpharm.com/
Company Name: Cato Research Chemicals Inc.  
Tel: 13342851930
Website: www.cato-chem.com/
Company Name: CHEMICAL LAND21  
Tel: 82- 2 -783 - 8063
Website: www.chemicalland21.com
Tags:17743-04-3 Related Product Information
36327-91-0 50887-69-9 3650-93-9 69304-49-0 58537-55-6 18002-26-1 5440-00-6 110100-09-9 23945-44-0 22126-44-9 874-14-6

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept